“Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program”. 2025. SKIN The Journal of Cutaneous Medicine 9 (4): s583. https://doi.org/10.25251/ed52rz19.